Dr. Ohl is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
200 Hawkins Dr
Iowa City, IA 52242Phone+1 319-356-7740Fax+1 319-384-7208
Education & Training
- University of Missouri-ColumbiaResidency, Family Medicine, 2003 - 2004
- University of WashingtonFellowship, Infectious Disease, 1999 - 2002
- University of California (San Francisco)Residency, Internal Medicine, 1996 - 1999
- Washington University in St. Louis School of MedicineClass of 1996
Certifications & Licensure
- CA State Medical License 1998 - Present
- IA State Medical License 2006 - 2026
- WA State Medical License 1999 - 2004
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Infectious Disease
- American Board of Preventive Medicine Addiction Medicine
Clinical Trials
- Rural PrEP Delivery Start of enrollment: 2018 Feb 01
Publications & Presentations
PubMed
- 50 citationsDexamethasone in hospitalised coronavirus-19 patients not on intensive respiratory supportKristina Crothers, Rian J. DeFaccio, Janet P. Tate, Patrick R. Alba, Matthew Bidwell Goetz
The European Respiratory Journal. 2021-11-25 - 8 citationsShould Human Immunodeficiency Virus Specialty Clinics Treat Patients With Hypertension or Refer to Primary Care? An Analysis of Treatment Outcomes.A Ben Appenheimer, Barbara G. Bokhour, D. Keith McInnes, Kelly Richardson, Andrew L Thurman
Open Forum Infectious Diseases. 2017-01-01 - 52 citationsRural residence is associated with delayed care entry and increased mortality among veterans with human immunodeficiency virus infection.Michael E. Ohl, Janet P. Tate, Mona Duggal, Melissa Skanderson, Matthew Scotch
Medical Care. 2010-12-01
Press Mentions
- University of Iowa Led Observational Study Reveals Remdesivir Can Lengthen Hospital Stay & Not Contribute to SurvivalJuly 21st, 2021
- Remdesivir Treatment Plan Kept COVID-19 Patients Hospitalized Longer, University of Iowa Research ShowsJuly 21st, 2021
- Remdesivir Treatment Period for COVID-19 Patients Kept Hospital Beds Full While They Were ScarceJuly 20th, 2021
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: